Keywords = Chronic myeloid leukemia
Number of Articles: 14
1. Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role

Volume 20, Issue 12, December 2019, Pages 3689-3695

Ikhwan Rinaldi; Ary Harryanto Reksodiputro; Sri Widia Jusman; Alida Harahap; Rianto Setiabudy; Septelia Inawati Wanandi; Karmel Tambunan; Catharina Suharti


2. Association between C1236T Genetic Variant of ABCB1 Gene and Molecular Response to Imatinib in Indonesian Chronic Myeloid Patients

Volume 20, Issue 11, November 2019, Pages 3331-3334

Ikhwan Rinaldi; Riki Nova; Reni Widyastuti; Rizky Priambodo; Instiaty Instiaty; Melva Louisa


3. Prevalence of BCR-ABL T315I Mutation in Malaysian Patients with Imatinib-Resistant Chronic Myeloid Leukemia

Volume 19, Issue 12, December 2018, Pages 3317-3320

Yuslina Mat Yusoff; Zahidah Abu Seman; Norodiyah Othman; Nor Rizan Kamaluddin; Ezalia Esa; Nor Amalina Zulkiply; Julia Abdullah; Zubaidah Zakaria


4. Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir

Volume 19, Issue 6, June 2018, Pages 1479-1485

Niyaz A Azad; Zafar A Shah; Arshad A Pandith; Mosin S Khan; Roohi Rasool; Javed Rasool; Shiekh A Aziz


9. Chronic Myeloid Leukemia - Prognostic Value of Mutations

Volume 16, Issue 17, December 2015, Pages 7415-7423